Monoclonal Antibody 75% Effective in Infants Against Respiratory Viral Infection

• 2022

  Log in to bookmark this resource.

  Log in
• Julie Robinson
DOI: https://dx.doi.org/10.1211/PJ.2022.1.132863

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article describes a study on nirsevimab, a monoclonal antibody that could protect infants from RSV infections. The study involved 1,490 infants and showed that nirsevimab was 75% effective in preventing RSV-related respiratory infections. Currently, only high-risk infants receive protection with palivizumab. Experts believe nirsevimab could be a game-changer by offering broader protection for all babies. It is given as a single injection before the RSV season and lasts for one year. However, its risks and benefits need careful evaluation before widespread use to ensure it is beneficial overall.

---

Tags

Focus Area: Infectious Disease

Audiences: EMS Clinicians; Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Respiratory Syncytial Viruses; Respiratory Tract Infections; Randomized Controlled Trials as Topic; Palivizumab

---

More like this

Disaster Preparedness in Neonatal Intensive Care Units 2017 · American Academy of Pediatrics (AAP) What’s Old Is New Again: Measles 2025 · Ann and Robert H. Lurie Children’s Hospital, Baylor College of Medicine, Vanderbilt University, Norton Children's Hospital, University of Louisville, Children's Hospital Colorado Strategies Used by Children’s Hospitals During the 2022 Viral Respiratory Surge 2025 · Seattle Children's Hospital, Ann and Robert H. Lurie Children’s Hospital, University of California San Francisco, UCSF Benioff Children's Hospital, St. Joseph’s Health, Boston Children's Hospital, University of Washington, Pediatric Pandemic Network (PPN)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---